Home / Import refusals / 1FX-8097216-8/10001/1

FDA Import Refusal 1FX-8097216-8/10001/1 — AndersonBrecon Inc.

AndersonBrecon Inc. — FEI 3003015528

The FDA refused shipment 1FX-8097216-8/10001/1 from AndersonBrecon Inc. (United States) on June 18, 2026. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75

Refusal Details

Date
June 18, 2026
Country
United States
Product Category
Drugs and Biologics
Product Code
61PCY74 TIRZEPATIDE (ANTI-DIABETIC)
Charges
75

Recent inspections

  • 1271016 (NAI Thu May 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1163069 (VAI Fri Feb 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1077016 (NAI Thu Jan 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 983024 (NAI Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 849321 (NAI Fri Sep 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources